10.1371/journal.pone.0020470 174
Type 2 diabetes (34.80%) and weight loss (14.71%) emerged as the most predominant indications, while others accounted for 3.92%, and unknown or missing constituted 46.57% (Table 1)
The 30ml multi-dose vial is the industry standard format for repeated sterile withdrawals
Patients with severe gastrointestinal conditions, such as gastroparesis or other disorders that affect gastric motility, may also experience worsening symptoms since semaglutide slows gastric emptying
However, as with any medication, GLP-1 agonists come with their own set of side effects
For Volume + Lightness When your appetite shrinks but your cravings havent, Pastabilities Lower Cal Pasta lets you enjoy more bites with fewer calories and carbs